Dr. Gilly Regev, Ph.D., ICD.D

Co-Founder

Gilly is a healthcare entrepreneur with a long track record of building companies that bring science-based products to market. She holds a Ph.D. in analytical and bioanalytical chemistry from the Hebrew University of Jerusalem and spent almost 20 years in the Nitric Oxide world.

In 2017, Dr Regev co-founded SaNOtize and served as its CEO, leading the company through product development, clinical trials, regulatory approvals, and global commercialization. Before that, she was part of the management team at Bovicor, an animal health company. NOWONDER builds on that work, bringing SaNOtize’s nitric oxide science to everyday consumer products.

Her work has been recognized with the YWCA Women of Distinction Award for Entrepreneur and Innovator of the Year (2021) and a place among the Top 25 Women Leaders in Biotechnology by The Healthcare Technology Report (2022).

Gilly is currently CEO of BridgeWell, a youth mental health technology company. She holds the ICD.D designation from the Institute of Corporate Directors and mentors early-stage founders at Creative Destruction Lab (CDL).

Dr. Gilly Regev, Ph.D., ICD.D